Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 83

1.

[DEVASYS - Development of an Online Tool to Support Systematic Evaluation of Intervention Projects in Prevention and Health Promotion].

Wichmann F, Brandes M, Jahn I, Muellmann S, Peters M, Pischke CR, Zeeb H.

Gesundheitswesen. 2019 Dec 16. doi: 10.1055/a-1005-6755. [Epub ahead of print] German.

PMID:
31842242
2.

Nonresonant Raman spectroscopy of isolated human retina samples complying with laser safety regulations for in vivo measurements.

Stiebing C, Schie IW, Knorr F, Schmitt M, Keijzer N, Kleemann R, Jahn IJ, Jahn M, Kiliaan AJ, Ginner L, Lichtenegger A, Drexler W, Leitgeb RA, Popp J.

Neurophotonics. 2019 Oct;6(4):041106. doi: 10.1117/1.NPh.6.4.041106. Epub 2019 Sep 3.

3.

Evaluation of the Optilite® analyser for determination of total complement activity and C3 and C4 fractions.

Nespola B, Comitogianni H, Jahn I, Goetz J.

Ann Biol Clin (Paris). 2019 Aug 1;77(4):447-452. doi: 10.1684/abc.2019.1453.

PMID:
31339492
4.

Mobile device and app use in paediatric emergency care: a survey of departmental practice in the UK and Ireland.

Jahn HK, Jahn IH, Roland D, Lyttle MD, Behringer W; PERUKI.

Arch Dis Child. 2019 Dec;104(12):1203-1207. doi: 10.1136/archdischild-2019-316872. Epub 2019 Jul 3.

PMID:
31270095
5.

Dead Sea climatotherapy versus topical steroid treatment for atopic dermatitis children: long-term follow-up study.

Marsakova A, Kudish A, Gkalpakiotis S, Jahn I, Arenberger P, Harari M.

J Dermatolog Treat. 2019 Apr 17:1-5. doi: 10.1080/09546634.2019.1605138. [Epub ahead of print]

PMID:
30995135
6.

Exposure and response prevention therapy augmented with naltrexone in kleptomania: a controlled case study using galvanic skin response for monitoring.

Olbrich S, Jahn I, Stengler K.

Behav Cogn Psychother. 2019 Sep;47(5):622-627. doi: 10.1017/S1352465819000213. Epub 2019 Mar 21.

PMID:
30894239
7.

Label-free SERS in biological and biomedical applications: Recent progress, current challenges and opportunities.

Zheng XS, Jahn IJ, Weber K, Cialla-May D, Popp J.

Spectrochim Acta A Mol Biomol Spectrosc. 2018 May 15;197:56-77. doi: 10.1016/j.saa.2018.01.063. Epub 2018 Jan 31. Review.

PMID:
29395932
8.

EEG-arousal regulation as predictor of treatment response in patients suffering from obsessive compulsive disorder.

Dohrmann AL, Stengler K, Jahn I, Olbrich S.

Clin Neurophysiol. 2017 Oct;128(10):1906-1914. doi: 10.1016/j.clinph.2017.07.406. Epub 2017 Jul 31.

PMID:
28826021
9.

Detection of Pseudomonas aeruginosa Metabolite Pyocyanin in Water and Saliva by Employing the SERS Technique.

Žukovskaja O, Jahn IJ, Weber K, Cialla-May D, Popp J.

Sensors (Basel). 2017 Jul 25;17(8). pii: E1704. doi: 10.3390/s17081704.

10.

The impact of attentional and emotional demands on memory performance in obsessive-compulsive disorder.

Fink J, Hendrikx F, Stierle C, Stengler K, Jahn I, Exner C.

J Anxiety Disord. 2017 Aug;50:60-68. doi: 10.1016/j.janxdis.2017.05.007. Epub 2017 May 25.

PMID:
28577416
11.

Likely impact of the UN Convention on disability on mental health services.

Jahn I, Becker T, Stengler K.

Curr Opin Psychiatry. 2017 Jul;30(4):318-322. doi: 10.1097/YCO.0000000000000340. Review.

PMID:
28525398
12.

Surface-enhanced Raman spectroscopy and microfluidic platforms: challenges, solutions and potential applications.

Jahn IJ, Žukovskaja O, Zheng XS, Weber K, Bocklitz TW, Cialla-May D, Popp J.

Analyst. 2017 Mar 27;142(7):1022-1047. doi: 10.1039/c7an00118e. Review.

PMID:
28276552
13.

Examples of sex/gender sensitivity in epidemiological research: results of an evaluation of original articles published in JECH 2006-2014.

Jahn I, Börnhorst C, Günther F, Brand T.

Health Res Policy Syst. 2017 Feb 15;15(1):11. doi: 10.1186/s12961-017-0174-z. Review.

14.

[Posttransplantation diabetes mellitus in patients after kidney transplantation - Incidence and risk factors].

Jahn I, Busch M, Ott U, Wolf G, Battefeld W.

Dtsch Med Wochenschr. 2016 Sep;141(19):e173-82. doi: 10.1055/s-0042-109448. Epub 2016 Sep 19. German.

PMID:
27642745
15.

Dead Sea ultraviolet climatotherapy for children with atopic dermatitis.

Kudish A, Marsakova A, Jahn I, Gkalpakiotis S, Arenberger P, Harari M.

Photodermatol Photoimmunol Photomed. 2016 Sep;32(5-6):254-261. doi: 10.1111/phpp.12250. Epub 2016 Jul 26.

PMID:
27379840
16.

[Sex/Gender-Responsive Health Research: New Funding Guidelines of the USA National Institutes of Health Can Bring a New Impetus to Germany].

Jahn I.

Gesundheitswesen. 2016 Jul;78(7):469-72. doi: 10.1055/s-0042-106647. Epub 2016 Jun 14. German.

PMID:
27300101
17.

[Sex/Gender-sensitive Research - A Survey of Epidemiologists in Germany].

Gansefort D, Jahn I.

Gesundheitswesen. 2016 Jul;78(7):460-6. doi: 10.1055/s-0042-100619. Epub 2016 Mar 18. German.

PMID:
26990610
18.

[Reaching Target Groups--Shaping Accessibility. Results of a Survey Among Experts on Recommendations for Science and Practice].

Jahn I, Gansefort D, Lehmann F, Walter U, Brand T.

Gesundheitswesen. 2015 Sep;77 Suppl 1:S47-8. doi: 10.1055/s-0035-1555924. Epub 2015 Sep 25. German.

PMID:
26406533
19.

Face-to-face Sun Protection Training and Text Messages Improve Sun Protection Behaviour in Adolescent Organ Transplant Recipients: HIPPOlino Feasibility Study.

Sachse MM, Böttcher S, Pape L, Wagner G, Mehls O, Klaus G, Laschewski G, Barz M, Jahn I, Zeeb H.

Acta Derm Venereol. 2016 Mar;96(3):341-5. doi: 10.2340/00015555-2234.

20.

[Epidemiology meets intersectionality].

Jahn I, Dirk G, Tilman B.

Gesundheitswesen. 2015 Apr;77(4):239. German. No abstract available.

PMID:
26034793
21.

Clinico-biological characteristics and treatment of type I monoclonal cryoglobulinaemia: a study of 64 cases.

Harel S, Mohr M, Jahn I, Aucouturier F, Galicier L, Asli B, Malphettes M, Szalat R, Brouet JC, Lipsker D, Fermand JP.

Br J Haematol. 2015 Mar;168(5):671-8. doi: 10.1111/bjh.13196. Epub 2014 Nov 2.

PMID:
25363150
22.

Elevated levels of cerebrospinal fluid neuron-specific enolase (NSE), but not S100B in major depressive disorder.

Schmidt FM, Mergl R, Stach B, Jahn I, Schönknecht P.

World J Biol Psychiatry. 2015 Feb;16(2):106-13. doi: 10.3109/15622975.2014.952776. Epub 2014 Sep 29.

PMID:
25264292
23.

[Gender aspects on mental health service utilization].

Stengler K, Jahn I.

Psychiatr Prax. 2015 Mar;42(2):63-4. doi: 10.1055/s-0034-1370277. Epub 2014 Aug 25. German. No abstract available.

PMID:
25153174
24.

Does "thinking about thinking" interfere with memory? An experimental memory study in obsessive-compulsive disorder.

Weber F, Hauke W, Jahn I, Stengler K, Himmerich H, Zaudig M, Exner C.

J Anxiety Disord. 2014 Oct;28(7):679-86. doi: 10.1016/j.janxdis.2014.07.009. Epub 2014 Jul 21.

PMID:
25127176
25.

[Sex- and gender-sensitive research in epidemiology and medicine: how can this be achieved? Aims and first results of the network "Sex-/Gender-Sensitive Research in Epidemiology, Neurosciences and Genetics/Cancer Research"].

Jahn I, Gansefort D, Kindler-Röhrborn A, Pfleiderer B.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014 Sep;57(9):1038-46. doi: 10.1007/s00103-014-2010-8. German.

PMID:
25077462
26.

[How do Prevention Projects Reach their Target Groups? Results of a Survey with Prevention Projects].

Brand T, Böttcher S, Jahn I.

Gesundheitswesen. 2015 Dec;77(12):960-5. doi: 10.1055/s-0034-1381992. Epub 2014 Jul 15. Review. German.

PMID:
25025293
27.

[Assertive community treatment in patients with severe obsessive-compulsive disorders].

Strauß M, Jahn I, Olbrich S, Beyrich-Kolbus U, Stengler K.

Fortschr Neurol Psychiatr. 2014 May;82(5):275-9. doi: 10.1055/s-0034-1366197. Epub 2014 May 13. German.

PMID:
24824206
28.

Elevated levels of cerebrospinal fluid neuron-specific enolase (NSE) in Alzheimer's disease.

Schmidt FM, Mergl R, Stach B, Jahn I, Gertz HJ, Schönknecht P.

Neurosci Lett. 2014 Jun 6;570:81-5. doi: 10.1016/j.neulet.2014.04.007. Epub 2014 Apr 16.

PMID:
24746933
29.

[Therapy refractory compulsive disorders and psychosocial interventions at the psychiatric institute outpatient service of the Leipzig University Clinic].

Stengler K, Jahn I, Olbrich S, Beyrich-Kolbus U, Strauß M.

Psychiatr Prax. 2013 Nov;40(8):453. German. No abstract available.

PMID:
24350362
30.

[Reaching Target Groups--Shaping Accessibility].

Walter U, Jahn I.

Gesundheitswesen. 2015 Sep;77 Suppl 1:S14-8. doi: 10.1055/s-0033-1334940. Epub 2013 Sep 30. German.

PMID:
24081569
31.

A population-based case-control study on social factors and risk of testicular germ cell tumours.

Schmeisser N, Conway DI, Stang A, Jahn I, Stegmaier C, Baumgardt-Elms C, Jöckel KH, Behrens T, Ahrens W.

BMJ Open. 2013 Sep 20;3(9):e003833. doi: 10.1136/bmjopen-2013-003833.

32.

[Prevention of Obesity and Promotion of Healthy Nutrition in Children by a Kindergarten-Based Intervention: An Evaluation Study].

Jahn I, Böttcher S; Projektteams.

Gesundheitswesen. 2015 Sep;77 Suppl 1:S54-5. doi: 10.1055/s-0032-1331254. Epub 2013 Aug 22. German.

PMID:
23970391
33.

Altered EEG lagged coherence during rest in obsessive-compulsive disorder.

Olbrich S, Olbrich H, Adamaszek M, Jahn I, Hegerl U, Stengler K.

Clin Neurophysiol. 2013 Dec;124(12):2421-30. doi: 10.1016/j.clinph.2013.05.031. Epub 2013 Aug 19.

PMID:
23968842
34.

Cerebrospinal fluid melanin-concentrating hormone (MCH) and hypocretin-1 (HCRT-1, orexin-A) in Alzheimer's disease.

Schmidt FM, Kratzsch J, Gertz HJ, Tittmann M, Jahn I, Pietsch UC, Kaisers UX, Thiery J, Hegerl U, Schönknecht P.

PLoS One. 2013 May 7;8(5):e63136. doi: 10.1371/journal.pone.0063136. Print 2013. Erratum in: PLoS One. 2013;8(6). doi:10.1371/annotation/7a79c40c-c1c2-41eb-a894-614c12e8c056.

35.

[Memorandum prevention research - research areas and methods].

Walter U, Nöcker G, Plaumann M, Linden S, Pott E, Koch U, Pawils S; unter Mitarbeit von, Altgeld T, Dierks ML, Frahsa A, Jahn I, Krauth C, Pomp M, Rehaag R, Robra BP, Süß W, Töppich J, Trojan A, von Unger H, Wildner M, Wright M.

Gesundheitswesen. 2012 Oct;74(10):e99-e113. doi: 10.1055/s-0032-1327759. Epub 2012 Nov 19. German.

PMID:
23165608
36.

EEG-vigilance regulation during the resting state in obsessive-compulsive disorder.

Olbrich S, Olbrich H, Jahn I, Sander C, Adamaszek M, Hegerl U, Reque F, Stengler K.

Clin Neurophysiol. 2013 Mar;124(3):497-502. doi: 10.1016/j.clinph.2012.08.018. Epub 2012 Sep 26.

PMID:
23022038
37.

[Memorandum - research funding of prevention].

Walter U, Gold C, Hoffmann W, Jahn I, Töppich J, Wildner M; (Redaktionsgruppe) unter Mitarbeit, Dubben S, Franze M, John J, Kliche T, Lehmann H, Naegele G, Nöcker G, Plaumann M, Pott E, Robra BP.

Gesundheitswesen. 2012 Aug;74(8-9):526-32. doi: 10.1055/s-0032-1323687. Epub 2012 Aug 31. German.

PMID:
22941740
38.

Mental health treatment seeking among patients with OCD: impact of age of onset.

Stengler K, Olbrich S, Heider D, Dietrich S, Riedel-Heller S, Jahn I.

Soc Psychiatry Psychiatr Epidemiol. 2013 May;48(5):813-9. doi: 10.1007/s00127-012-0544-3. Epub 2012 Jul 5.

PMID:
22763495
39.

Unstable EEG-vigilance in patients with cancer-related fatigue (CRF) in comparison to healthy controls.

Olbrich S, Sander C, Jahn I, Eplinius F, Claus S, Mergl R, Schönknecht P, Hegerl U.

World J Biol Psychiatry. 2012 Feb;13(2):146-52. doi: 10.3109/15622975.2010.545434. Epub 2011 Jan 19.

PMID:
21247259
40.

The serotonin transporter availability in untreated early-onset and late-onset patients with obsessive-compulsive disorder.

Hesse S, Stengler K, Regenthal R, Patt M, Becker GA, Franke A, Knüpfer H, Meyer PM, Luthardt J, Jahn I, Lobsien D, Heinke W, Brust P, Hegerl U, Sabri O.

Int J Neuropsychopharmacol. 2011 Jun;14(5):606-17. doi: 10.1017/S1461145710001604. Epub 2011 Jan 14.

41.

Nachdruck: : Matthias Jacob Schleiden an der Universität Jena.

Jahn I.

NTM. 2010;18(3):275-85. German. No abstract available.

PMID:
20668957
42.

[Epidemiological Societies for "gender-sensitive planning and implementation of the planned national cohort study"].

Jahn I, Bolte G, Spallek J.

Gesundheitswesen. 2010 Jul;72(7):383-6. doi: 10.1055/s-0030-1261917. Epub 2010 Jul 20. German. No abstract available.

PMID:
20648404
43.

Gender agenda: positive steps taken in Germany.

Zeeb H, Spallek J, Jahn I.

Nature. 2010 Jul 15;466(7304):315. doi: 10.1038/466315b. No abstract available.

PMID:
20631777
44.

Primary prevention from the epidemiology perspective: three examples from the practice.

Pigeot I, De Henauw S, Foraita R, Jahn I, Ahrens W.

BMC Med Res Methodol. 2010 Feb 3;10:10. doi: 10.1186/1471-2288-10-10.

45.

[Matthias Jacob Schleiden and the Meetings of German Natural Scientists and physicians].

Jahn I, Schmidt I.

Acta Hist Leopoldina. 2010;(55):9-21. German.

PMID:
21560511
46.

SPF 50 for organ transplant patients--over the top?

Sachse MM, Ehrich JH, Pape L, Pigeot I, Jahn I, Bahmer FA.

Nephrol Dial Transplant. 2009 Aug;24(8):2601. doi: 10.1093/ndt/gfp222. Epub 2009 May 21. No abstract available.

PMID:
19461008
47.

[Gender-sensitive epidemiological data analysis: methodological aspects and empirical outcomes. Illustrated by a health reporting example].

Jahn I, Foraita R.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2008 Jan;51(1):13-27. doi: 10.1007/s00103-008-0415-y. German.

PMID:
18185965
48.

Serum immunoglobulin free light chain assessment in rheumatoid arthritis and primary Sjogren's syndrome.

Gottenberg JE, Aucouturier F, Goetz J, Sordet C, Jahn I, Busson M, Cayuela JM, Sibilia J, Mariette X.

Ann Rheum Dis. 2007 Jan;66(1):23-7. Epub 2006 Mar 28.

49.

Diagnostic agreement in the histopathological evaluation of lung cancer tissue in a population-based case-control study.

Stang A, Pohlabeln H, Müller KM, Jahn I, Giersiepen K, Jöckel KH.

Lung Cancer. 2006 Apr;52(1):29-36. Epub 2006 Feb 14.

PMID:
16476504
50.

[Taking into consideration gender and sex. New chances to improve the quality of epidemiological and health research].

Jahn I.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2005 Mar;48(3):287-95. German.

PMID:
15768301

Supplemental Content

Support Center